Literature DB >> 10602027

Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.

M Delespine-Carmagnat1, G Bouvier, J Bertoglio.   

Abstract

Upon IL-2 stimulation of T lymphocytes, the IL-2 receptor (IL-2R) becomes phosphorylated on specific tyrosine residues which serve as docking sites for proteins containing SH2 or phosphotyrosine binding domains. To study the interaction of the IL-2Rbeta chain with Shc and STAT proteins, subdomains of the IL-2Rbeta chain were expressed as tyrosine-phosphorylated glutathione S-transferase fusion proteins and used to pull-down interacting proteins from Kit 225 cell lysates. These experiments provide direct biochemical evidence that binding to the IL-2R of the adaptor protein Shc requires phosphorylation of Tyr-338 in the IL-2Rbeta acidic subdomain. In addition, we report that STAT proteins that are activated by IL-2, i.e. STAT1, STAT3 and STAT5, indeed associate with the IL-2Rbeta chain. Both the A and B isoforms of STAT5 were found to associate with Tyr-510 of the IL-2Rbeta C-terminal region, depending on its phosphorylation. In contrast, STAT1 and STAT3 associated with the IL-2Rbeta chain through its acidic subdomain. These results indicate that the interaction between IL-2Rbeta and STAT1 or 3 does not require either phosphorylation of the receptor or even the presence of tyrosine residues of IL-2Rbeta. Thus, the IL-2R recruits STAT proteins through different modes of interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602027     DOI: 10.1002/1521-4141(200001)30:1<59::AID-IMMU59>3.0.CO;2-1

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  HLA-DR+ NK cells are mostly characterized by less mature phenotype and high functional activity.

Authors:  Sofya A Erokhina; Maria A Streltsova; Leonid M Kanevskiy; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  Immunol Cell Biol       Date:  2017-12-19       Impact factor: 5.126

2.  Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.

Authors:  Abhinav Arneja; Hannah Johnson; Laura Gabrovsek; Douglas A Lauffenburger; Forest M White
Journal:  J Immunol       Date:  2013-12-02       Impact factor: 5.422

Review 3.  Common gamma chain cytokines in combinatorial immune strategies against cancer.

Authors:  Stephanie R Pulliam; Roman V Uzhachenko; Samuel E Adunyah; Anil Shanker
Journal:  Immunol Lett       Date:  2015-11-17       Impact factor: 3.685

4.  Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.

Authors:  Mary Arnaud; Rym Mzali; Franck Gesbert; Catherine Crouin; Christine Guenzi; Claudine Vermot-Desroches; John Wijdenes; Geneviève Courtois; Olivier Bernard; Jacques Bertoglio
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

5.  Ectodomain shedding of interleukin-2 receptor beta and generation of an intracellular functional fragment.

Authors:  Pavel Montes de Oca; Valerie Malardé; Richard Proust; Alice Dautry-Varsat; Franck Gesbert
Journal:  J Biol Chem       Date:  2010-05-21       Impact factor: 5.157

Review 6.  Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

Authors:  Bharat B Aggarwal; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Shan R Gupta; Sheeja T Tharakan; Cemile Koca; Sanjit Dey; Bokyung Sung
Journal:  Ann N Y Acad Sci       Date:  2009-08       Impact factor: 5.691

7.  Facile discovery of surrogate cytokine agonists.

Authors:  Michelle Yen; Junming Ren; Qingxiang Liu; Caleb R Glassman; Timothy P Sheahan; Lora K Picton; Fernando R Moreira; Arjun Rustagi; Kevin M Jude; Xiang Zhao; Catherine A Blish; Ralph S Baric; Leon L Su; K Christopher Garcia
Journal:  Cell       Date:  2022-03-23       Impact factor: 66.850

8.  Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.

Authors:  Geok Choo Sim; Sheng Wu; Lei Jin; Patrick Hwu; Laszlo G Radvanyi
Journal:  Oncotarget       Date:  2016-06-14

9.  Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation.

Authors:  María Soledad Caldirola; María Guadalupe Rodríguez Broggi; María Isabel Gaillard; Liliana Bezrodnik; Norberto Walter Zwirner
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

10.  Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse.

Authors:  Roberto A Maldonado; Michelle A Soriano; L Carolina Perdomo; Kirsten Sigrist; Darrell J Irvine; Thomas Decker; Laurie H Glimcher
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.